A scoping review of strategies to increase black enrollment and retention in cancer clinical trials

NM Arring, L Aduse-Poku, E Jiagge, K Saylor… - JCO Oncology …, 2022 - ascopubs.org
To address health disparities faced by Black patients with cancer, it is critical that
researchers conducting cancer clinical trials (CCTs) equitably recruit and retain Black …

[HTML][HTML] Accentuating patient values in shared decision-making: a mixed methods development of an Online Value Clarification Tool and communication training in …

JLP van Gurp, LGG van Lent, N Stoel… - Patient Education and …, 2024 - Elsevier
Objective In the shared decision-making (SDM) process for potential early phase clinical
cancer trial participation, value clarification is highly recommended. However, exploration …

Patient values in patient-provider communication about participation in early phase clinical cancer trials: a qualitative analysis before and after implementation of an …

LGG van Lent, M van der Ham, MJA de Jonge… - BMC medical informatics …, 2024 - Springer
Background Patients with advanced cancer who no longer have standard treatment options
available may decide to participate in early phase clinical trials (ie experimental treatments …

Core values of patients with advanced cancer considering participation in an early-phase clinical trial: a qualitative study

JLP van Gurp, LGG van Lent, N Stoel… - Supportive Care in …, 2022 - Springer
Objective This article identifies the core values that play a role in patients' decision-making
process about participation in early-phase clinical cancer trials. Methods Face-to-face, semi …

“It All Depends”: Patient and Decision Partner Experiences in Cancer Clinical Trial Decision-Making

TF Gray, SJ Allgood, MT Nolan… - Qualitative Health …, 2022 - journals.sagepub.com
While the supporting role of families and friends has been widely recognized in cancer care,
little data exist on how they influence patients' decisions regarding clinical trial participation …

Decisional Conflict after Deciding on Potential Participation in Early Phase Clinical Cancer Trials: Dependent on Global Health Status, Satisfaction with …

LGG van Lent, MJA de Jonge, M van der Ham… - Cancers, 2022 - mdpi.com
Simple Summary Early phase clinical trials are an essential part of modern drug
development and thus the advance of anti-cancer therapies for patients. However, deciding …

Patient experiences of randomised placebo-controlled trial participation during end-of-life palliative cancer care

C Klasson, MH Frankling, CL Hagelin… - BMJ Supportive & …, 2024 - spcare.bmj.com
Background Performing clinical trials in palliative cancer care is known to be challenging.
Objective This study aimed to explore how patients with advanced cancer experienced their …

Patients' Recruitment and Retention in Clinical Trials: Subject's Intrinsic and Extrinsic Factors that Influence the Consent to Participate and Study Retention

RBS Gouveia - 2023 - search.proquest.com
In clinical trials, the recruitment of patients poses ongoing challenges, impacting the
sustainability of pharmaceutical research. Improving the efficiency and capacity of the …

[PDF][PDF] Core values of patients with advanced cancer considering participation in an early phase clinical trial

JLP van Gurp, LGG van Lent, NK Stoel… - … IN EARLY PHASE …, 2022 - pure.eur.nl
Core values of patients with advanced cancer considering participation in an early phase
clinical trial Page 67 Core values of patients with advanced cancer considering participation …